GUARDANT HEALTH, INC. Capital Expenditures
GUARDANT HEALTH, INC. (GH) reported Capital Expenditures of $17.34 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-30
- GUARDANT HEALTH, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $11.76M, a 108.16% increase year-over-year.
- GUARDANT HEALTH, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $5.58M, a 25.14% increase year-over-year.
- GUARDANT HEALTH, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $27.85M, a 47.54% increase year-over-year.
- GUARDANT HEALTH, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $10.35M, a 146.49% increase year-over-year.
- GUARDANT HEALTH, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $48.31M, a 37.68% increase from fiscal 2024.
- GUARDANT HEALTH, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $35.09M, a 71.26% increase from fiscal 2023.
- GUARDANT HEALTH, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $20.49M, a 73.55% decline from fiscal 2022.
- GUARDANT HEALTH, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $77.46M, a 3.23% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $17.34M 10-Q · filed 2026-07-30 | $45.19M derived: sum of 3 quarters · filed 2026-07-30 | $55.54M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $5.58M 10-Q · filed 2026-05-07 | $33.43M derived: sum of 2 quarters · filed 2026-05-07 | $43.78M derived: sum of 3 quarters · filed 2026-05-07 | $49.43M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $27.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $38.20M derived: sum of 2 quarters · filed 2026-02-19 | $43.85M derived: sum of 3 quarters · filed 2026-07-30 | $48.31M 10-K · filed 2026-02-19 |
| 2025-09-30 | $10.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $16.00M derived: sum of 2 quarters · filed 2026-07-30 | $20.46M 10-Q · filed 2025-10-29 | $39.33M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $5.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $10.11M 10-Q · filed 2026-07-30 | $28.98M derived: sum of 3 quarters · filed 2026-07-30 | $33.18M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $4.46M 10-Q · filed 2026-05-07 | $23.33M derived: sum of 2 quarters · filed 2026-05-07 | $27.53M derived: sum of 3 quarters · filed 2026-05-07 | $32.61M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $18.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $23.07M derived: sum of 2 quarters · filed 2026-02-19 | $28.15M derived: sum of 3 quarters · filed 2026-02-19 | $35.09M 10-K · filed 2026-02-19 |
| 2024-09-30 | $4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $9.28M derived: sum of 2 quarters · filed 2025-10-29 | $16.21M 10-Q · filed 2025-10-29 | $20.29M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $5.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $12.01M 10-Q · filed 2025-07-30 | $16.09M derived: sum of 3 quarters · filed 2026-02-19 | $18.46M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $6.93M 10-Q · filed 2025-04-30 | $11.01M derived: sum of 2 quarters · filed 2026-02-19 | $13.38M derived: sum of 3 quarters · filed 2026-02-19 | $19.90M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $6.45M derived: sum of 2 quarters · filed 2026-02-19 | $12.96M derived: sum of 3 quarters · filed 2026-02-19 | $20.49M 10-K · filed 2026-02-19 |
| 2023-09-30 | $2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $8.88M derived: sum of 2 quarters · filed 2024-11-06 | $16.41M 10-Q · filed 2024-11-06 | $26.41M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $6.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $14.04M 10-Q · filed 2024-08-07 | $24.04M derived: sum of 3 quarters · filed 2025-02-20 | $45.76M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $7.52M 10-Q · filed 2024-05-09 | $17.52M derived: sum of 2 quarters · filed 2025-02-20 | $39.25M derived: sum of 3 quarters · filed 2025-02-20 | $62.28M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $31.73M derived: sum of 2 quarters · filed 2025-02-20 | $54.76M derived: sum of 3 quarters · filed 2025-02-20 | $77.46M 10-K · filed 2025-02-20 |
| 2022-09-30 | $21.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $44.76M derived: sum of 2 quarters · filed 2023-11-06 | $67.46M 10-Q · filed 2023-11-06 | $92.08M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $23.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $45.73M 10-Q · filed 2023-08-03 | $70.36M derived: sum of 3 quarters · filed 2024-02-22 | $92.51M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $22.70M 10-Q · filed 2023-05-09 | $47.33M derived: sum of 2 quarters · filed 2024-02-22 | $69.47M derived: sum of 3 quarters · filed 2024-02-22 | $88.15M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $24.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $46.77M derived: sum of 2 quarters · filed 2024-02-22 | $65.45M derived: sum of 3 quarters · filed 2024-02-22 | $75.03M 10-K · filed 2024-02-22 |
| 2021-09-30 | $22.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $40.82M derived: sum of 2 quarters · filed 2022-11-03 | $50.41M 10-Q · filed 2022-11-03 | $57.69M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $18.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $28.26M 10-Q · filed 2022-08-04 | $35.54M derived: sum of 3 quarters · filed 2023-02-23 | $45.33M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $9.59M 10-Q · filed 2022-05-05 | $16.87M derived: sum of 2 quarters · filed 2023-02-23 | $26.65M derived: sum of 3 quarters · filed 2023-02-23 | $36.16M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $7.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $17.07M derived: sum of 2 quarters · filed 2023-02-23 | $26.57M derived: sum of 3 quarters · filed 2023-02-23 | $36.17M 10-K · filed 2023-02-23 |
| 2020-09-30 | $9.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $19.29M derived: sum of 2 quarters · filed 2021-11-04 | $28.89M 10-Q · filed 2021-11-04 | $35.98M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $9.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $19.11M 10-Q · filed 2021-08-05 | $26.19M derived: sum of 3 quarters · filed 2022-02-24 | $32.07M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $9.60M 10-Q · filed 2021-05-06 | $16.69M derived: sum of 2 quarters · filed 2022-02-24 | $22.56M derived: sum of 3 quarters · filed 2022-02-24 | $25.61M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $7.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $12.96M derived: sum of 2 quarters · filed 2022-02-24 | $16.01M derived: sum of 3 quarters · filed 2022-02-24 | $18.72M 10-K · filed 2022-02-24 |
| 2019-09-30 | $5.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $8.92M derived: sum of 2 quarters · filed 2020-11-05 | $11.63M 10-Q · filed 2020-11-05 | $14.56M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $5.75M 10-Q · filed 2020-08-06 | $8.68M derived: sum of 3 quarters · filed 2021-02-25 | $14.60M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $2.71M 10-Q · filed 2020-05-07 | $5.64M derived: sum of 2 quarters · filed 2021-02-25 | $11.55M derived: sum of 3 quarters · filed 2021-02-25 | $18.89M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $8.84M derived: sum of 2 quarters · filed 2021-02-25 | $16.18M derived: sum of 3 quarters · filed 2021-02-25 | $20.20M 10-K · filed 2021-02-25 |
| 2018-09-30 | $5.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $13.25M derived: sum of 2 quarters · filed 2019-11-07 | $17.27M 10-Q · filed 2019-11-07 | $20.23M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $7.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $11.36M 10-Q · filed 2019-08-07 | $14.32M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2018-03-31 | $4.02M 10-Q · filed 2019-05-10 | $6.98M derived: sum of 2 quarters · filed 2020-03-02 | ||
| 2017-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $6.68M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $3.72M 10-Q · filed 2018-11-19 | |||
| 2016-12-31 | $1.77M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |